Generation of HER2-specific antibody immunity during trastuzumab adjuvant therapy associates with reduced relapse in resected HER2 breast cancer
暂无分享,去创建一个
B. Necela | E. Perez | C. Calfa | D. Northfelt | M. Pegram | K. Knutson | C. Erskine | N. Norton | R. Clynes | W. Tan | K. Tenner | C. Mccarl | G. Colón-Otero | N. Fox | K. Ballman | Kathleen S. Tenner